USE OF A NAKED CLASS I ANTI-CEA MONOCLONAL ANTIBODY IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING A CEA AND OR NCA EXPRESSING CANCER

摘要

The present invention provides a composition comprising naked humanized, chimeric, and human anti-CEA antibodies and a therapeutic agent, which is useful for treatment of CEA expressing cancers and other diseases, and methods of use in treatment using this composition.